The client
Capital Cell, Europe’s first online investment platform, specializes in biomedicine, one of most profitable sectors in the world. With Capital Cell, a user can invest in highly profitable companies with a big social impact. What’s more, these companies have undergone an exclusive analysis to reduce inherent risks for investors.
